Alzheimer's Phase 2 Clinical Trial Success

joel.desrochers • January 20, 2021

Share this article

The Eli Lilly Alzheimer's Phase 2 clinical trial shows promising results and success in slowing the decline seen in dementia patients.  The New York Times  reported on the success of the small clinical trial by Eli Lilly and Company January 11, 2021.  Neurology Diagnostics proudly announces that we are a top enrollment site for the Eli Lilly's Alzheimer's Phase 2 clinical trial, enrolling just under 5% of the of the 272 patients studied world-wide.  This is an exciting breakthrough for Alzheimer's reseach showing promising, first of its kind success in slowing Alzheimer's disease progression.  

The Eli Lilly research trial studies the effects of the drug, donanemab, a monoclonal antibody that works by binding to a small part of the hard plaques in the brain made of protein or amyloid that is the hallmark of Alzheimer's disease.  Patients receive the drug by infusion every 4 weeks.  The Eli Lilly Alzheimer's Phase 2 clinical trial results show study participants that received the drug had a 32% reduction in the rate of decline, compared with those who took the placebo.  "In 6 to 12 months, plaques were gone and stayed gone" according to Dr. Daniel Skovronsky, Eli Lilly's chief scientific officer.

Neurology Diagnostics is continuing in the next phase of the Eli Lilly trial and currently enrolling patients for a limited time.  These scientific advancements exemplify our motive to remain on the leading edge of treatment giving us and our patient's hope.  

As we continue forward on the path toward fighting the onset and progression of Alzheimer's disease, we are recruiting for the follow up Eli Lilly study, as well as, other Alzheimer treatment trials future studies.  If you or someone you know may be interested in participating, please let us know.

Recent Posts

By joel.desrochers • July 10, 2025
Managing multiple sclerosis demands a comprehensive approach that includes physical therapy alongside traditional medications. With targeted exercises and stretches, you can protect your strength and mobility.
By joel.desrochers • July 2, 2025
Our dedicated team at NDx Clinical Research recently traveled to attend an exclusive investigator meeting for an exciting new clinical trial evaluating a new biosimilar Botox compound as a potential treatment for chronic migraines!
By joel.desrochers • June 3, 2025
Wondering if a clinical trial might be right for you? These research studies can open doors to new treatments but come with tradeoffs worth considering.
By joel.desrochers • May 2, 2025
Having a tremor can be alarming, but it doesn’t automatically mean you have Parkinson’s disease. Understanding the different causes of tremors and how they differ is essential to getting the treatment you need.
By joel.desrochers • April 11, 2025
FAA medical exams can make or break your flying career. Our guide walks you through what examiners check, which documents to bring, and simple pre-exam adjustments that prevent certification problems. 
By joel.desrochers • March 10, 2025
Could your diet be triggering your migraines? Certain foods, from aged cheese to red wine, might be the culprit behind those debilitating headaches. Learn which common foods to watch for and how to identify your personal triggers.
By joel.desrochers • February 18, 2025
Unexplained numbness, tingling, or muscle weakness could be signs of a nerve or muscle disorder. Electrodiagnostic medicine helps pinpoint the cause so you can get the answers you need to develop the proper treatment.
By joel.desrochers • January 27, 2025
Curious about clinical trials but not sure if they’re right for you? They’re critical for advancing medical treatments, but many people don’t realize how they can benefit from participating. Learn more about how they work and why they matter.
By joel.desrochers • December 9, 2024
Worried about your memory? Get a free cognitive assessment! Learn what to expect during the 15-minute evaluation and discover potential next steps like consulting with a neurologist or participating in clinical trials. Schedule a free cognitive testing NOW
By joel.desrochers • December 3, 2024
Dementia affects millions, altering memory, thinking, and daily life. Here we explore the basics of dementia, from signs and diagnosis to managing care with empathy. Explore expert tips to support your loved one, and yourself, on this journey.
Show More